First-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (nccRCC): Updated follow-up for KEYNOTE-427 cohort B von Suárez, C., Lee, J.-L., Ziobro, M., Gafanov, R.A., Matveev, V.B., Donskov, F., Pouliot, F., Alekseev, B.Y., Wiechno, P.J., Tomczak, P., Climent, M.A., Shin, S.J., Kloss Silverman, R., Perini, R.F., Schloss, C., McDermott, D.F., Atkins, M.B.

Volltext

KEYNOTE-427 cohort A: Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC) von Donskov, F., McDermott, D.F., Lee, J.L., Szczylik, C., Malik, J., Alekseev, B.Y., Larkin, J.M.G., Matveev, V.B., Airatovich Gafanov, R., Tomczak, P., Tykodi, S.S., Geertsen, P.F., Wiechno, P., Shin, S.J., Pouliot, F., Alonso Gordoa, T., Kloss Silverman, R., Perini, R.F., Schloss, C., Atkins, M.B.

Volltext

The KEYNOTE-630 Trial: A Phase 3 Study of Adjuvant Pembrolizumab in High-Risk Locally Advanced (LA) Cutaneous Squamous Cell Carcinoma (cSCC) von Schenker, M., Klochikhin, M., Kirtbaya, D., Mortier, L., Gschnell, M., Robert, C., Meyer, N., Flatz, L., Dalle, S., Beylot-Barry, M., Eigentler, T., Silverman, R. Kloss, Gumuscu, B., Yuan, J., Bratland, A.

Volltext

948P - First-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (nccRCC): Updated follow-up for KEYNOTE-427 cohort B von Suárez, C., Lee, J.-L., Ziobro, M., Gafanov, R.A., Matveev, V.B., Donskov, F., Pouliot, F., Alekseev, B.Y., Wiechno, P.J., Tomczak, P., Climent, M.A., Shin, S.J., Kloss Silverman, R., Perini, R.F., Schloss, C., McDermott, D.F., Atkins, M.B.

Volltext

948PFirst-line pembrolizumab (pembro) monotherapy for advanced non-clear cell renal cell carcinoma (nccRCC): Updated follow-up for KEYNOTE-427 cohort B von Suárez, C, Lee, J-L, Ziobro, M, Gafanov, R A, Matveev, V B, Donskov, F, Pouliot, F, Alekseev, B Y, Wiechno, P J, Tomczak, P, Climent, M A, Shin, S J, Kloss Silverman, R, Perini, R F, Schloss, C, McDermott, D F, Atkins, M B

Volltext

949PFirst-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up for KEYNOTE-427 cohort A von Larkin, J M G, Tykodi, S S, Donskov, F, Lee, J-L, Szczylik, C, Malik, J, Alekseev, B Y, Matveev, V B, Gafanov, R A, Tomczak, P, Geertsen, P F, Wiechno, P J, Shin, S J, Pouliot, F, Alonso Gordoa, T, Kloss Silverman, R, Perini, R F, Schloss, C, McDermott, D F, Atkins, M B

Volltext

First-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up for KEYNOTE-427 cohort A von Larkin, J.M.G., Tykodi, S.S., Donskov, F., Lee, J.-L., Szczylik, C., Malik, J., Alekseev, B.Y., Matveev, V.B., Gafanov, R.A., Tomczak, P., Geertsen, P.F., Wiechno, P.J., Shin, S.J., Pouliot, F., Alonso Gordoa, T., Kloss Silverman, R., Perini, R.F., Schloss, C., McDermott, D.F., Atkins, M.B.

Volltext

949P - First-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up for KEYNOTE-427 cohort A von Larkin, J.M.G., Tykodi, S.S., Donskov, F., Lee, J.-L., Szczylik, C., Malik, J., Alekseev, B.Y., Matveev, V.B., Gafanov, R.A., Tomczak, P., Geertsen, P.F., Wiechno, P.J., Shin, S.J., Pouliot, F., Alonso Gordoa, T., Kloss Silverman, R., Perini, R.F., Schloss, C., McDermott, D.F., Atkins, M.B.

Volltext

871PKEYNOTE-427 cohort A: Pembrolizumab monotherapy as first-line therapy in advanced clear cell renal cell carcinoma (ccRCC) von Donskov, F, McDermott, D F, Lee, J L, Szczylik, C, Malik, J, Alekseev, B Y, Larkin, J M G, Matveev, V B, Airatovich Gafanov, R, Tomczak, P, Tykodi, S S, Geertsen, P F, Wiechno, P, Shin, S J, Pouliot, F, Alonso Gordoa, T, Kloss Silverman, R, Perini, R F, Schloss, C, Atkins, M B

Volltext

Sequential parallel comparison design with binary and time‐to‐event outcomes von Silverman, Rachel Kloss, Ivanova, Anastasia, Fine, Jason

Volltext

Phase 3 study of first-line treatment with pembrolizumab + belzutifan + lenvatinib or pembrolizumab/quavonlimab + lenvatinib versus pembrolizumab + lenvatinib for advanced renal ce... von Choueiri, Toni K., Plimack, Elizabeth R., Powles, Thomas, Voss, Martin H, Gurney, Howard, Silverman, Rachel Kloss, Perini, Rodolfo F., Rodriguez-Lopez, Karla, Rini, Brian I.

Volltext